Verastem Inc (NASDAQ:VSTM)
| 3.18 Delayed Data As of 4:14pm ET |  -0.025 / -0.78%Today’s Change | 1.14 Today|||52-Week Range 4.93 | +49.06% Year-to-Date |
Latest VSTM News | Press Releases
| Why Verastem Stock Spiked Today Sep 20 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.20 |
| Today’s open | 3.14 |
| Day’s range | 3.14 - 3.27 |
| Volume | 162,164 |
| Average volume (3 months) | 2,850,184 |
| Market cap | $498.9M |
Data as of 4:14pm ET, 09/24/2021
Growth & Valuation
| Earnings growth (last year) | +77.92% |
| Earnings growth (this year) | +21.21% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +6.07% |
| P/E ratio | NM |
| Price/Sales | 17.64 |
| Price/Book | 4.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VTGNVistaGen Therapeutic... | -0.12 | -4.07% |
| EPZMEpizyme Inc | -0.13 | -2.38% |
| RDUSRadius Health Inc | -0.06 | -0.47% |
| MGTXMeiraGTx Holdings PL... | -0.21 | -1.55% |
Data as of 4:14pm ET, 09/24/2021
Financials
| Next reporting date | November 9, 2021 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $18.5M |
| Annual profit (last year) | -$67.7M |
| Net profit margin | -365.77% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Needham, Massachusetts |
Forecasts
